Darolutamide+ADT Post-RP w/o ePLND in hrPC: Briganti 2019
Clinical trial NCT07282197 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07282197
- Sponsor
- Peking University First Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-01
- Primary completion
- 2029-03-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.